Wall Street Journal Reported MetLife Seeds $1.2B Fund of Funds With Secondary Sale
$MET
Life Insurance
Finance
Wall Street Journal Reported MetLife Seeds $1.2B Fund of Funds With Secondary Sale
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such
AM Best has assigned indicative Long-Term Issue Credit Ratings of "a-" (Excellent) to senior unsecured issues, "bbb+" (Good) to subordinated issues, and "bbb" (Good) to preferred stock to the recently filed shelf registration of MetLife, Inc. (MetLife) (headquartered in New, NY) (NYSE:MET). The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registrations, which expired. MetLife's proforma financial leverage and the historical interest coverage ratios are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on A
MetLife, Inc. (NYSE:MET) today announced that Jane Slusark will join the company as chief communications officer, effective June 9, 2025. In this role, she will oversee the company's global communications strategy, including internal and external communications and media relations. "Jane brings strategic vision, operational rigor and deep expertise to this role," said Michael Roberts, chief marketing officer at MetLife. "She has a proven track record of building trust and deepening engagement, which will be instrumental as we continue to enhance our reputation with customers, employees, and communities around the world." Slusark comes to MetLife from Principal Financial Group, where she w
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul
S-3ASR - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
13F-HR - METLIFE INC (0001099219) (Filer)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
3 - METLIFE INC (0001099219) (Issuer)
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul
MetLife, Inc. (NYSE:MET) today announced its first quarter 2025 results. Earnings Per Share Return on Equity (ROE) 1Q 2025 1Q 2025 Net Income $ 1.28 ROE 14.9 % Adjusted Earnings $ 1.96 Adjusted ROE 14.4 % Net income increased 10% to $879 million. Premiums, fees and other revenues (PFOs) increased 14% to $13.6 billion. Adjusted earnings rose 1% to $1.3 billion. Higher life underwriting margins, volume growth and variable investment income were partially offset by unfavorable foreign currency impacts and lower recurring interest margins. Book value increased 2% to $35.16 per share. A
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a first quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430216095/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers b